FDA reviewer confirms drug's alluring side effect

An FDA reviewer is agreeing with Allergan that its glaucoma drug Lumigan also has an alluring side effect: it lengthens and thickens eyelashes [1]. Allergan is seeking the agency's approval to sell the drug as Latisse to enhance upper eyelashes. And, as the Wall Street Journal notes, an approval would be a first for eyelash care. Report [2]